AMANDA MANNING: Open Payments
NPI 1518459965 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 41 payments from 13 companies in 2025. Trend: 2023 $646 · 2024 $1,071 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $153 |
| PFIZER INC. | 8 | $149 |
| ABBVIE INC. | 9 | $143 |
| Novo Nordisk Inc | 4 | $78 |
| Abbott Laboratories | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
Products named: NURTEC ODT, FARXIGA, QULIPTA, UBRELVY, Ozempic, FREESTYLE LIBRE 3, AIRSUPRA, GEMTESA.
Industry payments across AR — which companies pay providers there.
